Register for our free email digests:
Division of Illumina Inc.
Latest From Bayer Consumer Care
Top management changes have taken place at Sandoz Turkey, while Alvimedica, a leading Turkish medical devices company, has a new CEO and the Bayer Consumer Care Business has appointed a new country manager. Meanwhile, Sanofi has launched a platform to support Turkish pharmaceutical researchers through its global network and facilities.
Bayer discontinues ad comparing Alka-Seltzer Plus Night Cold & Flu, which is indicated for nasal decongestion, with P&G's NyQuil Cold & Flu, which is not.
Bayer discontinues an ad comparing Alka-Seltzer Plus Night Cold & Flu, which is indicated for nasal decongestion, with P&G's NyQuil Cold & Flu, which is not. The review centered on NAD's “apples to oranges” principle that marketers should not mislead on the similarities of competing formulas.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April through May 2014.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Therapeutic Areas
- Gynecological, Urological
- Neurology, Nervous System
- Western Europe
- Parent & Subsidiaries
- Illumina Inc.
- Senior Management
- Contact Info
Phone: 1223 885900
CPC4, Capital Park
Fulbourn, CB21 5XE
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.